We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

0001193125-19-282510 Sample Contracts

Standard Contracts

REVENUE INTEREST FINANCING AGREEMENT between KARYOPHARM THERAPEUTICS INC., as the Company, and HEALTHCARE ROYALTY PARTNERS III, L.P. AND HEALTHCARE ROYALTY PARTNERS IV, L.P., collectively as Investor Dated September 14, 2019
Revenue Interest Financing Agreement • November 4th, 2019 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • New York

This REVENUE INTEREST FINANCING AGREEMENT (this “Agreement”) dated as of September 14, 2019 (the “Effective Date”) is between KARYOPHARM THERAPEUTICS INC., a Delaware corporation (the “Company”), and HEALTHCARE ROYALTY PARTNERS III, L.P. and HEALTHCARE ROYALTY PARTNERS IV, L.P. Each of the Company and any Investor are referred to in this Agreement as a “Party” and collectively as the “Parties”.